This invention relates generally to a method and apparatus for delivering a medical device and more specifically to a method and apparatus for delivering a medical device percutaneously.
Numerous systems for percutaneous catheter delivery of implants have been devised over the years in order to assist physicians in delivering and positioning implants within the human body in a minimally invasive manner. A classic problem with many of these percutaneous delivery systems is that the systems themselves can often adversely affect the position of the device that is being implanted. In many instances, if the delivery system is adversely influencing the positioning of the implant, the physician is forced to estimate this influential effect on implant position and take this into consideration when assessing final implant position prior to release. Further, the final released position of the implant may ultimately differ from its position when still attached to the delivery system. Additionally, any implant movement that occurs following release can adversely effect the final position. These positional deviations can in turn cause less desirable final results (such as a residual leak in the case of septal occluders or even device embolization).
Modem medical technology has produced a number of medical implants which are designed for compression into a small size tube or catheter to facilitate introduction into the vasculature. Many of these implants are subsequently expandable for either occlusion of defects or holes in the heart as well as defects along the walls of a biological passageway or blood vessel. For example a septal occluder can be used to repair a hole in the heart wall. One such occluder is described in U.S. Pat. No. 5,425,744, the entire disclosure of which is hereby incorporated by reference. While the occluder noted above is a permanent implant which, when implanted, is designed to remain in place, it can be recovered at a variety of stages during the implantation procedure. To understand the difficulty in positioning the implant some knowledge of the anatomy of the heart is required.
The human heart is divided into four compartments or chambers. The left and right atria are located in the upper portion of the heart and the left and right ventricles are located in the lower portion of the heart. The left and right atria are separated from each other by a muscular wall, the intraatrial septum, while the right and left ventricles are separated by the intraventricular septum. Either congenitally or by acquisition, abnormal openings, holes or shunts can occur between the chambers of the heart or the great vessels, causing shunting of blood through the opening. These holes or shunts may develop between the left and right atria along the intraatrial septum. Such deformities are usually congenital and result from the incomplete formation of the septum, or wall, between chambers during fetal life when the heart forms from a folded tube into a four chambered, two unit system.
These deformities can cause significant problems. Ultimately, the ill effects of these defects cause added strain on the heart which may result in heart failure if the defects are not corrected. One such defect, a patent foramen ovale (PFO), is a persistent, one-way, usually flap-like opening in the wall between the right atrium and left atrium of the heart. The PFO is the most common abnormality of fetal origin among the normal adult population. The opening between the right atrium and left atrium is formed because the embryonic left-sided septum primum is thinner than the embryonic septum secundum and overlaps the septum secundum. Since left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap typically stays closed. Under certain conditions, however, RA pressure can exceed LA pressure creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. This is of particular importance with patients who are prone to forming venous thrombus such as those with deep vein thrombosis or clotting abnormalities.
Transcatheter (percutaneous) closure of PFOs has become possible using a variety of mechanical closure devices, allowing patients to avoid the potential side effects often associated with standard anticoagulation therapies. These devices consist of a metallic structural framework combined with a synthetic material. The function of the material is to encourage ingrowth and encapsulation of the implant by a fibrous tissue capsule covered by a neointima. Other intracardiac defects, also currently treated with such devices, include atrial septal defects (ASDs), ventricular septal defects (VSDs), and left atrial appendages (LAAs).
The present invention, in part, addresses the issues related to these devices.
The system according to the invention combines a collet, having at least two arms which are movable between and open state and a closed state, with a flexible elongated tubular member having a first end and a second end and defining a lumen. In one position, a portion of the flexible elongated tubular member covers part of the collet collapsing the arms of the collet into its closed state to form an inner chamber. By moving the relative position between the collet and the first end of the flexible elongated tubular member, the collet extends from the flexible elongate tubular member and is self-biased to expand to its open state. The flexible elongate member is sized and shaped to fit within a blood vessel. A wire is disposed within the lumen and is attached to the collet. The wire is movable between a first position and a second position within the flexible elongate tubular member, thereby moving the collet relative to the first end of the flexible tubular member.
In one embodiment, the inner chamber of the collet is sized and configured to capture an attachment means (also referred to, herein, as an engagement means or member) of a medical device. In a further embodiment, the delivery device further includes a handle attached to the second end of the elongate member. In another embodiment, the delivery device further includes an actuator at least partially disposed in the handle for changing the relative position of the collet and the first end of the flexible tubular member. The delivery device includes a spring bias to bias the position of the first end of the flexible elongate tubular member with respect to the collet. In one aspect, the invention relates to a system which includes the delivery device described above and a septal occluder removably affixed to the engagement device.
In another aspect, the invention relates to a method for repairing a cardiac defect which includes the step of providing a delivery system including a flexible elongate tubular member being sized and shaped to fit within a vessel and having a wire disposed therethrough. The wire is movable between a first position and a second position relative to the flexible elongate tubular member. One end of the wire is attached to a collet having at least two arms movable between a first open state and a second collapsed state and forming an inner chamber when in the collapsed state. The inner chamber being sized and configured to capture an engagement member of a septal occluder. A first end of the flexible elongate tubular member surrounds a portion of the collet in a first position and is substantially retracted from the collet in a second position. The system also includes a septal occluder with an engagement member.
The steps of the method also include capturing the engagement member within the inner chamber of the collet, inserting the first end of the flexible elongate tubular member into the body of the patient and positioning the first end of the elongate member with attached septal occluder proximate to the defect. The steps of the method can further include releasing the engagement member from the collet and removing the elongate flexible member from the body of the patient.
In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention. In the following description, various embodiments of the present invention are described with reference to the following drawings, in which:
Referring to
Referring to
Referring to
Referring to
In operation, the engagement member 85 of the medical device 80 is held by the jaws 65 of the collet 50. The device 10 is inserted into a blood vessel of the patient and the medical device 80 is positioned at the desired spot in the body. At that point the device 80 is released. If the device 80 needs to be repositioned the jaws 65 grasp the engagement means 85 and the device 80 is moved. Once the device 80 is in the proper position, the jaws 65 are opened releasing the device 80 and the flexible, elongated, tubular member 20 is removed from the blood vessel.
While the present invention has been described in terms of certain exemplary preferred embodiments, it will be readily understood and appreciated by one of ordinary skill in the art that it is not so limited and that many additions, deletions and modifications to the preferred embodiments may be made within the scope of the invention as hereinafter claimed. Accordingly, the scope of the invention is limited only by the scope of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
1889330 | Humes et al. | Nov 1932 | A |
2625967 | Stull | Jan 1953 | A |
3874388 | King et al. | Apr 1975 | A |
4007743 | Blake | Feb 1977 | A |
4422654 | Grunig | Dec 1983 | A |
4477105 | Wittman et al. | Oct 1984 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4985014 | Orejola | Jan 1991 | A |
5030199 | Barwick et al. | Jul 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5042976 | Ishitsu et al. | Aug 1991 | A |
5057114 | Wittich et al. | Oct 1991 | A |
5073166 | Parks et al. | Dec 1991 | A |
5108420 | Marks | Apr 1992 | A |
5112310 | Grobe | May 1992 | A |
5186567 | Evenson et al. | Feb 1993 | A |
5190528 | Fonger et al. | Mar 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5211515 | Hirabayashi | May 1993 | A |
5217484 | Marks | Jun 1993 | A |
5222973 | Sharpe et al. | Jun 1993 | A |
5284488 | Sideris | Feb 1994 | A |
5304195 | Twyford, Jr. et al. | Apr 1994 | A |
5308357 | Lichtman | May 1994 | A |
5312341 | Turi | May 1994 | A |
5318589 | Lichtman | Jun 1994 | A |
5334217 | Das | Aug 1994 | A |
5350397 | Palermo et al. | Sep 1994 | A |
5357979 | Imran | Oct 1994 | A |
5403338 | Milo | Apr 1995 | A |
5425744 | Fagan et al. | Jun 1995 | A |
5431416 | Thornton | Jul 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5443464 | Russell et al. | Aug 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5507811 | Koike et al. | Apr 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5545138 | Fugoso et al. | Aug 1996 | A |
5577299 | Thompson et al. | Nov 1996 | A |
5578045 | Das | Nov 1996 | A |
5620461 | Muijs Van De Moer et al. | Apr 1997 | A |
5626604 | Cottone, Jr. | May 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5638827 | Palmer et al. | Jun 1997 | A |
5665100 | Yoon | Sep 1997 | A |
5683411 | Kavteladze et al. | Nov 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
5709707 | Lock et al. | Jan 1998 | A |
5713952 | Vanney et al. | Feb 1998 | A |
5720754 | Middleman et al. | Feb 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5733294 | Forber et al. | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5746765 | Kleshinski et al. | May 1998 | A |
5776075 | Palmer | Jul 1998 | A |
5776162 | Kleshinski | Jul 1998 | A |
5797958 | Yoon | Aug 1998 | A |
5800516 | Fine et al. | Sep 1998 | A |
5807405 | Vanney et al. | Sep 1998 | A |
5810884 | Kim | Sep 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5861003 | Latson et al. | Jan 1999 | A |
5868753 | Schatz | Feb 1999 | A |
5876437 | Vanney et al. | Mar 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5888200 | Walen | Mar 1999 | A |
5891130 | Palermo et al. | Apr 1999 | A |
5895391 | Farnholtz | Apr 1999 | A |
5895404 | Ruiz | Apr 1999 | A |
5902317 | Kleshinski et al. | May 1999 | A |
5904695 | Krueger | May 1999 | A |
5904703 | Gilson | May 1999 | A |
5919200 | Stambaugh et al. | Jul 1999 | A |
5928250 | Koike et al. | Jul 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5957976 | Vanney et al. | Sep 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5989242 | Saadat et al. | Nov 1999 | A |
5993474 | Ouchi | Nov 1999 | A |
5993475 | Lin et al. | Nov 1999 | A |
6007558 | Ravenscroft et al. | Dec 1999 | A |
6024756 | Huebsch et al. | Feb 2000 | A |
6030007 | Bassily et al. | Feb 2000 | A |
6030405 | Zarbatany et al. | Feb 2000 | A |
6056760 | Koike et al. | May 2000 | A |
6077291 | Das | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6086610 | Duerig et al. | Jul 2000 | A |
6113609 | Adams | Sep 2000 | A |
6117143 | Hynes et al. | Sep 2000 | A |
6117159 | Huebsch et al. | Sep 2000 | A |
6129755 | Mathis et al. | Oct 2000 | A |
6146325 | Lewis et al. | Nov 2000 | A |
6149664 | Kurz | Nov 2000 | A |
6171329 | Shaw et al. | Jan 2001 | B1 |
6174322 | Schneidt | Jan 2001 | B1 |
6190373 | Palermo et al. | Feb 2001 | B1 |
6206907 | Marino et al. | Mar 2001 | B1 |
6209886 | Estes et al. | Apr 2001 | B1 |
6214029 | Thill et al. | Apr 2001 | B1 |
6221092 | Koike et al. | Apr 2001 | B1 |
6261916 | Re et al. | Jul 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6290674 | Roue et al. | Sep 2001 | B1 |
6296622 | Kurz et al. | Oct 2001 | B1 |
6312446 | Huebsch et al. | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
6342064 | Koike et al. | Jan 2002 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6352531 | O'Connor et al. | Mar 2002 | B1 |
6355052 | Neuss et al. | Mar 2002 | B1 |
6368330 | Hynes et al. | Apr 2002 | B1 |
6375671 | Kobayashi et al. | Apr 2002 | B1 |
6379368 | Corcoran et al. | Apr 2002 | B1 |
6387104 | Pugsley, Jr. et al. | May 2002 | B1 |
6402772 | Amplatz et al. | Jun 2002 | B1 |
6415693 | Simon et al. | Jul 2002 | B1 |
6440152 | Gainor et al. | Aug 2002 | B1 |
6482224 | Michler et al. | Nov 2002 | B1 |
6494888 | Laufer et al. | Dec 2002 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6551344 | Thill | Apr 2003 | B2 |
6596013 | Yang et al. | Jul 2003 | B2 |
6623508 | Shaw et al. | Sep 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6673100 | Diaz et al. | Jan 2004 | B2 |
6849081 | Sepetka et al. | Feb 2005 | B2 |
7344553 | Opolski et al. | Mar 2008 | B2 |
20010037129 | Thill | Nov 2001 | A1 |
20020010481 | Jayaraman et al. | Jan 2002 | A1 |
20020019648 | Akerfeldt et al. | Feb 2002 | A1 |
20020026208 | Roe et al. | Feb 2002 | A1 |
20020052572 | Franco et al. | May 2002 | A1 |
20020077555 | Schwartz et al. | Jun 2002 | A1 |
20020096183 | Stevens et al. | Jul 2002 | A1 |
20020099389 | Michler et al. | Jul 2002 | A1 |
20020107531 | Schreck et al. | Aug 2002 | A1 |
20020120323 | Thompson et al. | Aug 2002 | A1 |
20020128680 | Pavlovic | Sep 2002 | A1 |
20020183786 | Girton | Dec 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030045893 | Ginn | Mar 2003 | A1 |
20030050665 | Ginn | Mar 2003 | A1 |
20030059640 | Marton et al. | Mar 2003 | A1 |
20030100920 | Akin et al. | May 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030181945 | Opolski | Sep 2003 | A1 |
20030195530 | Thill | Oct 2003 | A1 |
20030208232 | Blaeser et al. | Nov 2003 | A1 |
Number | Date | Country |
---|---|---|
1222897 | Jul 2002 | EP |
WO 9807375 | Feb 1998 | WO |
WO 9918862 | Apr 1999 | WO |
WO 9918864 | Apr 1999 | WO |
WO 9918870 | Apr 1999 | WO |
WO 9918871 | Apr 1999 | WO |
WO 0178596 | Oct 2001 | WO |
WO 03077733 | Sep 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20040181256 A1 | Sep 2004 | US |